Iluvien
Payments companies reported to CMS as associated with Iluvien. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Iluvien, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Iluvien
These are the largest totals companies reported as associated with Iluvien. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Lisa Faia | Royal Oak, MI | Retina Specialist | $101,390.19 |
| Mark Dacey | Denver, CO | Ophthalmology | $67,055.74 |
| Jorge Fortun | Palm Beach Gardens, FL | Ophthalmology | $64,827.73 |
| Michael Singer | San Antonio, TX | Ophthalmology | $48,444.73 |
| Donald Mazzulla | New Orleans, LA | Retina Specialist | $44,500.70 |
| Dilsher Dhoot | Santa Barbara, CA | Retina Specialist | $43,450.10 |
| Daniel Kiernan | Sarasota, FL | Ophthalmology | $43,396.39 |
| Peter Chang | Waltham, MA | Ophthalmology | $32,931.08 |
| Stephen Anesi | Waltham, MA | Ophthalmology | $29,042.30 |
| Arjun Sood | Blue Ash, OH | Ophthalmology | $27,816.67 |
Prescribed Iluvien?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.